Order Article Reprints

Ortega MA, Pekarek L, Fraile-Martinez O, Garcia-Montero C, Saez MA, Asúnsolo A, Alvarez-Mon MA, Monserrat J, Ruiz-Llorente L, García-Honduvilla N, et al. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies. Current Oncology. 2022; 29(4):2442-2453. https://doi.org/10.3390/curroncol29040198

Ortega, Miguel A., Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla, and et al. 2022. "Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies" Current Oncology 29, no. 4: 2442-2453. https://doi.org/10.3390/curroncol29040198

Ortega, M. A., Pekarek, L., Fraile-Martinez, O., Garcia-Montero, C., Saez, M. A., Asúnsolo, A., Alvarez-Mon, M. A., Monserrat, J., Ruiz-Llorente, L., García-Honduvilla, N., Albillos, A., Buján, J., Alvarez-Mon, M., & Guijarro, L. G. (2022). Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies. Current Oncology, 29(4), 2442-2453. https://doi.org/10.3390/curroncol29040198